The Benign Breast Disease Risk (BBDRisk) Dx™ Test is a risk assessment tool developed by Silbiotech, Inc for patients who have been diagnosed with Atypical and other hyperplasias. Contact your physician today to order the test. To learn more about the BBDRisk Dx™ Test – visit our website today.